Literature DB >> 17008574

Detection of co-occurring mental illness among adult patients in the New Jersey substance abuse treatment system.

Hsou Mei Hu1, Anna Kline, Frederick Y Huang, Douglas M Ziedonis.   

Abstract

OBJECTIVES: We assessed the detection of mental illness in an adult population of substance abuse patients and the rate of referral for mental health treatment.
METHODS: We obtained combined administrative records from 1994 to 1997 provided by the New Jersey substance abuse and mental health systems and estimated detection and referral rates of patients with co-occurring disorders (n = 47,379). Mental illness was considered detected if a diagnosis was in the record and considered undetected if a diagnosis was not in the record but the patient was seen in both treatment systems within the same 12-month period. Predictors of detection and referral were identified.
RESULTS: The detection rate of co-occurring mental illness was 21.9% (n=10364); 57.9% (n=6001) of these individuals were referred for mental health treatment. Methadone maintenance clinics had the lowest detection rate but the highest referral rate. Male, Hispanic, and African American patients, as well as those who used heroin or were in the criminal justice system, had a higher risk of mental illness not being detected. Once detected, African American patients, heroin users, and patients in the criminal justice system were less likely to be referred for treatment.
CONCLUSIONS: There is a need to improve the detection of mental illness among substance abuse patients and to provide integrated treatment.

Entities:  

Mesh:

Year:  2006        PMID: 17008574      PMCID: PMC1586138          DOI: 10.2105/AJPH.2005.072736

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  34 in total

Review 1.  Integrated treatment of co-occurring mental illness and addiction: clinical intervention, program, and system perspectives.

Authors:  Douglas M Ziedonis
Journal:  CNS Spectr       Date:  2004-12       Impact factor: 3.790

2.  Co-occurring disorders among mentally ill jail detainees. Implications for public policy.

Authors:  K M Abram; L A Teplin
Journal:  Am Psychol       Date:  1991-10

Review 3.  Dual diagnosis of major mental illness and substance disorder: an overview.

Authors:  R E Drake; P McLaughlin; B Pepper; K Minkoff
Journal:  New Dir Ment Health Serv       Date:  1991

4.  Integrated treatment for dually diagnosed homeless adults.

Authors:  R E Drake; N A Yovetich; R R Bebout; M Harris; G J McHugo
Journal:  J Nerv Ment Dis       Date:  1997-05       Impact factor: 2.254

5.  The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization.

Authors:  R C Kessler; C B Nelson; K A McGonagle; M J Edlund; R G Frank; P J Leaf
Journal:  Am J Orthopsychiatry       Date:  1996-01

6.  Violence and severe mental illness: the effects of substance abuse and nonadherence to medication.

Authors:  M S Swartz; J W Swanson; V A Hiday; R Borum; H R Wagner; B J Burns
Journal:  Am J Psychiatry       Date:  1998-02       Impact factor: 18.112

7.  Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods.

Authors:  H J Steadman; E P Mulvey; J Monahan; P C Robbins; P S Appelbaum; T Grisso; L H Roth; E Silver
Journal:  Arch Gen Psychiatry       Date:  1998-05

Review 8.  Issues in the psychiatric treatment of African Americans.

Authors:  F M Baker; C C Bell
Journal:  Psychiatr Serv       Date:  1999-03       Impact factor: 3.084

9.  The detection and treatment of posttraumatic distress and substance intoxication in the acute care inpatient setting.

Authors:  Douglas Zatzick; Joan Russo; Frederick Rivara; Peter Roy-Byrne; Gregory Jurkovich; Wayne Katon
Journal:  Gen Hosp Psychiatry       Date:  2005 Jan-Feb       Impact factor: 3.238

10.  Validity of psychiatric diagnoses in patients with substance use disorders: is the interview more important than the interviewer?

Authors:  H R Kranzler; R M Kadden; J A Burleson; T F Babor; A Apter; B J Rounsaville
Journal:  Compr Psychiatry       Date:  1995 Jul-Aug       Impact factor: 3.735

View more
  7 in total

1.  Adapting problem-solving therapy for depressed older adults in methadone maintenance treatment.

Authors:  Daniel Rosen; Jennifer Q Morse; Charles F Reynolds
Journal:  J Subst Abuse Treat       Date:  2010-10-30

2.  Using information technology to evaluate the detection of co-occurring substance use disorders amongst patients in a state mental health system: implications for co-occurring disorder state initiatives.

Authors:  Frederick Y Huang; Douglas M Ziedonis; Hsou Mei Hu; Anna Kline
Journal:  Community Ment Health J       Date:  2007-08-10

3.  Interrelationship of substance use and psychological distress over the life course among a cohort of urban African Americans.

Authors:  Kerry M Green; Katarzyna A Zebrak; Judith A Robertson; Kate E Fothergill; Margaret E Ensminger
Journal:  Drug Alcohol Depend       Date:  2011-12-19       Impact factor: 4.492

4.  Prevalence and factors associated with anxiety and depression among type 2 diabetes in Qassim: A descriptive cross-sectional study.

Authors:  Abdulrahman A Al-Mohaimeed
Journal:  J Taibah Univ Med Sci       Date:  2017-05-31

5.  Association of co-occurring opioid or other substance use disorders with increased healthcare utilization in patients with depression.

Authors:  Veer Vekaria; Budhaditya Bose; Sean M Murphy; Jonathan Avery; George Alexopoulos; Jyotishman Pathak
Journal:  Transl Psychiatry       Date:  2021-05-03       Impact factor: 6.222

6.  Principles of Care for Young Adults With Co-Occurring Psychiatric and Substance Use Disorders.

Authors:  Andrea E Spencer; Sarah E Valentine; Jennifer Sikov; Amy M Yule; Heather Hsu; Eliza Hallett; Ziming Xuan; Michael Silverstein; Lisa Fortuna
Journal:  Pediatrics       Date:  2021-01       Impact factor: 7.124

7.  Implementing Key Strategies for Successful Network Integration in the Quebec Substance-Use Disorders Programme.

Authors:  Marie-Josée Fleury; Michel Perreault; Guy Grenier; Armelle Imboua; Serge Brochu
Journal:  Int J Integr Care       Date:  2016-04-05       Impact factor: 5.120

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.